FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.xver-r5.r4.r4
Resource TypeValueSet
IdValueSet-R5-v3-RoleClassMolecularPart-for-R4.json
FHIR VersionR4
Sourcehttp://hl7.org/fhir/uv/xver-r5.r4/0.0.1-snapshot-2/ValueSet-R5-v3-RoleClassMolecularPart-for-R4.html
URLhttp://hl7.org/fhir/5.0/ValueSet/R5-v3-RoleClassMolecularPart-for-R4
Version0.0.1-snapshot-2
Statusactive
Date2025-09-01T22:37:05.372278+10:00
NameR5_v3_RoleClassMolecularPart_for_R4
TitleCross-version VS for R5.RoleClassMolecularPart for use in FHIR R4
Realmuv
Authorityhl7
DescriptionThis cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v3-RoleClassMolecularPart|2.0.0 for use in FHIR R4. Concepts not present here have direct `equivalent` mappings crossing all versions from R5 to R4.

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
v3-RoleClassRoleClass

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R5-v3-RoleClassMolecularPart-for-R4

This value set expansion contains 2 concepts.

CodeSystemDisplayDefinition
  ACTMhttp://terminology.hl7.org/CodeSystem/v3-RoleClassactive moiety

The molecule or ion that is responsible for the intended pharmacological action of the drug substance, excluding those appended or associated parts of the molecule that make the molecule an ester, salt (including a salt with hydrogen or coordination bonds), or other noncovalent derivative (such as a complex, chelate, or clathrate).

Examples: heparin-sodium and heparin-potassium have the same active moiety, heparin; the active moiety of morphine-hydrochloride is morphine.

  PARThttp://terminology.hl7.org/CodeSystem/v3-RoleClasspart

Definition: an association between two Entities where the playing Entity (the part) is a component of the whole (scoper) in the sense of an integral structural component, that is distinct from other parts in the same whole, has a distinct function in the whole, and, as an effect, the full integrity of the whole depends (to some degree) on the presence of this part, even though the part may often be separable from the whole.

Discussion: Part is defined in opposition to (a) ingredient (not separable), (b) content (not a functional component), and (c) member (not functionally distinct from other members).


Source1

{
  "resourceType": "ValueSet",
  "id": "R5-v3-RoleClassMolecularPart-for-R4",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "fhir"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r5.r4"
        },
        {
          "url": "version",
          "valueString": "0.0.1-snapshot-2"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0,
      "_valueInteger": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/5.0/ImplementationGuide/hl7.fhir.uv.xver-r5.r4"
          }
        ]
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/5.0/ImplementationGuide/hl7.fhir.uv.xver-r5.r4"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/5.0/ValueSet/R5-v3-RoleClassMolecularPart-for-R4",
  "version": "0.0.1-snapshot-2",
  "name": "R5_v3_RoleClassMolecularPart_for_R4",
  "title": "Cross-version VS for R5.RoleClassMolecularPart for use in FHIR R4",
  "status": "active",
  "experimental": false,
  "date": "2025-09-01T22:37:05.372278+10:00",
  "publisher": "FHIR Infrastructure",
  "contact": [
    {
      "name": "FHIR Infrastructure",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/fiwg"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v3-RoleClassMolecularPart|2.0.0 for use in FHIR R4. Concepts not present here have direct `equivalent` mappings crossing all versions from R5 to R4.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "compose": {
    "include": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
        "version": "3.1.0",
        "concept": [
          {
            "code": "ACTM",
            "display": "active moiety"
          },
          {
            "code": "PART",
            "display": "part"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2025-09-01T22:37:05.372276+10:00",
    "contains": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
        "version": "3.1.0",
        "code": "ACTM",
        "display": "active moiety"
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
        "version": "3.1.0",
        "code": "PART",
        "display": "part"
      }
    ]
  }
}